Abstract:Prostate cancer is one of the most severe male malignant tumors, which ranks second in mortality rate among all tumors. Traditional methods of treatment for prostate cancer produce obvious side effects and a high recurrence rate. Cancer stem cells are considered to be a group of cells that determine the proliferation, metastasis, and drug resistance of tumor. Prostate cancer therapy based on microRNAs and prostate cancer stem cells (PCSCs) has been a research hot spot in this field. Previous studies have reported that miR-197 plays an important role in the occurrence and development of prostate cancer, but the molecular mechanism of miR-197 on the development of prostate cancer has not been reported yet. In this study, we verified that miR-197 is significantly overexpressed in prostate cancer tissues and prostate cancer cells. Then, we verified that miR-197 expression affects the proliferation, invasion, and metastasis of prostate cancer cells by regulating integrin subunit alpha V (ITGAV) expression through STAT5 pathway, and the results indicated that the miR-197 inhibitor can be a prostate cancer suppressor. Then we synthesized the AbCD133@GNR@MSNs@miR-197 inhibitor drug carrier, in which 35.42 μg of the miR-197 inhibitor could be loaded in 1 mg of AbCD133@GNR@MSNs. The AbCD133@GNR@MSNs@miR-197 inhibitor demonstrated good photothermal properties and photothermal controlled-release properties. The modified CD133 antibodies on the surface of the nano drug carrier helped more drug carriers to enter the PCSCs. The pharmacodynamic effects of the AbCD133@GNR@MSNs@miR-197 inhibitor on PCSCs in vivo and in vitro were studied under near-infrared radiation. The results showed that the AbCD133@GNR@MSNs@miR-197 inhibitor prepared in this study could not only significantly suppress the development of PCSCs through ITGAV/STAT5 pathway but also significantly suppress the growth of PCSC solid tumors. In short, our study verified that miR-197 regulates the development of PCSCs through STAT5 pathway by targeting ITGAV, and the AbCD133@MSNs@GNR@miR-197 inhibitor could be a potential suppressor used in prostate cancer treatment. In short, our study found that miR-197 affected the development of prostate cancer by regulating ITGAV. The AbCD133@GNR@MSNs@miR-197 inhibitor prepared in this study could suppress the development and growth of PCSCs in vitro and in solid tumors not only by targeting the ITGAV but also through photothermal therapy. Our study not only provides a theoretical basis for the clinical treatment of prostate cancer but also provides a research scheme of drug loading and microRNA-based photothermal controlled therapy for prostate cancer.

Inhibitory Effect of Microrna-29C on Proliferation and Invasion of Human Prostate Cancer Cell Line LNCaP

The Effects of Mirnas-107 on Cell Proliferation, Senescence and Invasion of Pancreatic Cancer PANC-1 Cells

MiR-29a Suppresses Prostate Cell Proliferation and Induces Apoptosis Via KDM5B Protein Regulation.

Up-regulated Mir-29C Inhibits Cell Proliferation and Glycolysis by Inhibiting SLC2A3 Expression in Prostate Cancer

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

MicroRNA-193a-3p Inhibits Cell Proliferation in Prostate Cancer by Targeting Cyclin D1

Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

Effects of Microrna-29 Family Members on Proliferation and Invasion of Gastric Cancer Cell Lines

Microrna-29C Inhibits Cell Proliferation by Targeting NASP in Human Gastric Cancer

MicroRNA-1297 Inhibits Prostate Cancer Cell Proliferation and Invasion by Targeting the AEG-1/Wnt Signaling Pathway

Expression and Effect of Mir-769-5p on Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer

The LINC00852/miR-29a-3p/JARID2 axis regulates the proliferation and invasion of prostate cancer cell

The screening of siRNA to AMACR and the influence of LNCaP

MiR-197 Inhibitor Loaded AbCD133@MSNs@GNR Affects the Development of Prostate Cancer Through Targeting ITGAV

Low Expression of Microrna-30C Promotes Prostate Cancer Cells Invasion Involved in Downregulation of KRAS Protein.

MicroRNA-181b Expression in Prostate Cancer Tissues and Its Influence on the Biological Behavior of the Prostate Cancer Cell Line PC-3.

MicroRNA-29c Functions As a Tumor Suppressor by Targeting VEGFA in Lung Adenocarcinoma

Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13

Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1

MiR-199a-3p Suppresses Proliferation and Invasion of Prostate Cancer Cells by Targeting Smad1

MicroRNA-218 Inhibits the Migration, Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties of Prostate Cancer Cells.